Connect with us

Business

No reliable evidence that ESG investing produces above-average returns

Published

3 minute read

From the Fraser Institute

By Steven Globerman

Despite growing skepticism among investors, as evidenced by their withdrawal of billions of dollars from ESG equity funds so far in 2024, many finance industry leaders continue to claim that ESG-focused investing produces above-average returns.

But is that true?

Environmental, social and governance (ESG) is a movement designed to pressure businesses and investors to pursue larger social goals. According to ESG theory, firms that receive poor ratings from ESG rating agencies should lose investment dollars. Yet the claim that ESG-focused investing can help investors do well by doing good has received surprisingly little empirical support from academic studies.

However, according to a new study published by the Fraser Institute, which tracked 310 companies listed on the Toronto Stock Exchange from 2013 to 2020, neither ESG rating upgrades nor downgrades were related in a statistically significant way to the stock market performance of companies.

Moreover, because the study finds that ESG ratings changes—which, when released, are effectively new information for investors—are not consistently related to financial returns, ESG ratings are likely not relevant to the expected future profitability of publicly listed companies in Canada.

This of course raises the question—if new information (i.e. ratings changes) about a company’s ESG-related practises is not statistically related to equity returns from investing in that company, why do money managers pay for the services of ESG rating companies?

One possible reason is that managers pass a substantial share of the costs along to customers who are willing to sacrifice financial returns (due to higher management fees) to express their commitment to environmental sustainability and other social causes. Another possible reason is that promoting ESG-focused investment alternatives appears to have been, at least until recently, an effective marketing tool.

But again, the empirical evidence suggests there’s no reliable statistical relationship between ESG-focused investing and the risk-adjusted returns earned by investors. And since asset managers typically charge higher fees for ESG-focused mutual funds, ESG investment strategies are more likely to underperform than overperform conventional investment strategies.

Certainly, if some percentage of investors choose to pursue ESG-related investment strategies, even at the cost of lower risk-adjusted investment returns, there should be no legal or regulatory restrictions on doing so. However, securities regulators should closely monitor the investment industry to ensure it provides reliable and up-to-date information about the financial performance of ESG-focused investment products that portfolio managers market to the public.

At the same time, when ESG advocates push for more government-mandated ESG disclosures from companies in Canada, policymakers should be wary of any claims that greater disclosure mandates will improve the financial performance of companies.

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Business

Bill would prevent congressional members from trading stocks

Published on

From The Center Square

By

U.S. Sen. Mark Kelly, D-Arizona, has co-introduced a bill to prevent members of Congress from trading stocks.

The Ban Congressional Stock Trading Act requires all members of Congress, their spouses and dependent children to put their stocks in a qualified blind trust or divest the holding. In doing so, Kelly’s office said this ensures members and their family members cannot use inside information to influence trades and profit off those transactions.

“As Americans work hard to keep up with rising costs, the last thing they should have to worry about is whether their elected representatives are using inside information to make a quick buck,” said Kelly in a press release. “This isn’t rocket science; the only way to stop insider trading in Congress is to stop members of Congress from trading stocks. Period.”

Kelly said he believes he already has the support of the American people.

Pointing to a survey by the Program for Public Consultation at the University of Maryland’s School of Public Policy, Kelly said 86% of Americans back such a measure. That includes 88% of Democrats, 87% of Republicans and 81% of Independents.

“Fixing this would go a long way toward restoring trust — and fixing what’s broken in Washington,” said Kelly.

U.S. Sen. Jon Ossoff, D-Georgia, also introduced the bill. Ossoff said members of congress have “extraordinary access to confidential information” at the same time they are making federal policy. Because of this, Ossoff said members of Congress should not be playing the stock market.

“Stock trading by members of Congress massively erodes public confidence in Congress and creates a serious appearance of impropriety, which is why we should ban stock trading by members of Congress altogether,” said Ossoff.

The bill is co-sponsored by Senators Brian Schatz, D-Hawaii, Tammy Duckworth, D-Illinois, Tammy Baldwin, D-Wisconsin, Jeanne Shaheen, D-New Hampshire, Raphael Warnock, D-Georgia, and Michael Bennet, D-Colorado. Bennett, who is The Center Square for governor of Colorado, said it is “common-sense legislation.”

Kelly has already placed his assets in qualified blind trusts, released his official Senate schedule and refused corporate PAC contributions for his campaign.

Continue Reading

Business

Big Pharma company Regeneron buys 23andMe, set to acquire genetic data of millions

Published on

From LifeSiteNews

Regeneron said it will act ethically when it acquires data on 15 million Americans from 23andMe.

A Big Pharma company will acquire genetic data on 15 million people after purchasing DNA testing company 23andMe in a bankruptcy auction.

“Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction,” CNN reported.

“Regeneron said it will comply with 23andMe’s privacy policies and applicable laws with respect to the use of customer data and that it is ready to detail its intended use of the data to a court-appointed overseer,” the news outlet reported.

23andMe already suffered a privacy breach of its sensitive genetic information.

While Regeneron said it will protect data, many people may still have concerns.

Users wishing to delete their genetic data can do so, according to California Attorney General Rob Bonta, who issued a “consumer alert” when 23andMe first filed for bankruptcy in March. He explained how people can log into their account and delete their data.

Continue Reading

Trending

X